US equities |
GOOGL $285.12 ▼-12.24% GOOG $283.21 ▼-12.02% MSFT $524.36 ▼-1.25% META $629.27 ▲+2.74% MU $945.34 ▼-3.85% AMZN $246.13 ▼-3.33% NVDA $213.42 ▼-0.91% AAPL $349.41 ▲+1.62%
FinancialContent

Personalis, Inc. - Common Stock (NQ:PSNL)

16.01 +0.01 (+0.06%)
Delayed Quote Updated: 12:16 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Personalis: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Personalis Reports Third Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
From Personalis, Inc.
Via Business Wire
News headline image
Analyst Ratings for Personalis ↗
 
Via Benzinga
News headline image
Recap: Personalis Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Earnings Outlook For Personalis ↗
 
Via Benzinga
News headline image
Personalis to Announce Third Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
From Personalis, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 112 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
News headline image
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Reports Second Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at Upcoming Investor Conferences
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce Second Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
From Personalis, Inc.
Via Business Wire
News headline image
Dr. Kenneth J. Widder Joins Personalis Board of Directors
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
From Personalis, Inc.
Via Business Wire
News headline image
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Reports First Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce First Quarter 2023 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
From Personalis, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >